SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Smruthi Organics - Quaterly Results

14 Nov 2022 Evaluate
The sales surged to Rs. 432.68 millions, up 41.61% for the September 2022 quarter as against Rs. 305.54 millions during the corresponding quarter previous year.A meek growth of 2.39% was reported for the quarter ended September 2022 to Rs. 28.68  millions from Rs. 28.01 millions.Operating Profit reported a sharp decline to 40.51 millions from 49.48 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 432.68 305.54 41.61 723.41 614.50 17.72 1333.72 1265.01 5.43
Other Income 0.16 2.23 -92.83 0.47 4.04 -88.37 5.83 5.61 3.92
PBIDT 40.51 49.48 -18.13 57.98 95.66 -39.39 190.12 290.95 -34.66
Interest 2.16 2.98 -27.52 3.35 5.25 -36.19 9.84 10.93 -9.97
PBDT 38.35 46.50 -17.53 54.63 90.41 -39.58 180.28 280.02 -35.62
Depreciation 10.56 10.50 0.57 21.71 21.00 3.38 42.56 39.46 7.86
PBT 27.79 36.00 -22.81 32.92 69.41 -52.57 137.72 240.56 -42.75
TAX -0.89 7.99 -111.14 1.20 16.07 -92.53 33.90 69.48 -51.21
Deferred Tax -8.22 0.21 -4014.29 -8.35 -0.03 27733.33 -1.70 1.42 -219.72
PAT 28.68 28.01 2.39 31.72 53.34 -40.53 103.82 171.08 -39.31
Equity 114.46 114.46 0.00 114.46 114.46 0.00 114.46 114.46 0.00
PBIDTM(%) 9.36 16.19 -42.19 8.01 15.57 -48.51 14.25 23.00 -38.02

Smruthi Organics Share Price

120.45 0.20 (0.17%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×